People

Shyam Prabhakaran, MD MS

Dr. Shyam Prabhakaran is an internationally recognized leader in vascular neurology and stroke research and treatment. He currently serves as principal investigator of the Chicago regional coordinating center in the National Institutes of Health’s stroke trials network (NIH StrokeNet).

New York Presbyterian Hospital-Columbia
New York, NY
- Vascular Neurology
2006

Columbia University Mailman School of Public Health
New York, NY
MS - Epidemiology
2006

New York Presbyterian Hospital-Cornell
New York, NY
- Neurology
2004

Rutgers New Jersey Medical School
Newark, NJ
MD - Medicine
2000

Role of the Heart in Dementia Etiology in the Absence of Atrial Fibrillation or Stroke.
Prabhakaran S, Greenland P. Role of the Heart in Dementia Etiology in the Absence of Atrial Fibrillation or Stroke. JAMA. 2022 03 22; 327(12):1133-1134.
PMID: 35315907

A mixed methods analysis of caller-emergency medical dispatcher communication during 9-1-1 calls for out-of-hospital cardiac arrest.
Richards CT, McCarthy DM, Markul E, Rottman DR, Lindeman P, Prabhakaran S, Klabjan D, Holl JL, Cameron KA. A mixed methods analysis of caller-emergency medical dispatcher communication during 9-1-1 calls for out-of-hospital cardiac arrest. Patient Educ Couns. 2022 Mar 05.
PMID: 35304072

Effect of dihydropyridine calcium channel blockers on blood pressure variability in the SPRINT trial: a treatment effects approach.
de Havenon A, Petersen N, Wolcott Z, Goldstein E, Delic A, Sheibani N, Anadani M, Sheth KN, Lansberg M, Turan T, Prabhakaran S. Effect of dihydropyridine calcium channel blockers on blood pressure variability in the SPRINT trial: a treatment effects approach. J Hypertens. 2022 03 01; 40(3):462-469.
PMID: 34694261

Race-Ethnic Disparities in Rates of Declination of Thrombolysis for Stroke.
Mendelson SJ, Zhang S, Matsouaka R, Xian Y, Shah S, Lytle BL, Solomon N, Schwamm LH, Smith EE, Saver JL, Fonarow G, Holl J, Prabhakaran S. Race-Ethnic Disparities in Rates of Declination of Thrombolysis for Stroke. Neurology. 2022 Feb 28.
PMID: 35228335

Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study.
Yaghi S, Shu L, Bakradze E, Salehi Omran S, Giles JA, Amar JY, Henninger N, Elnazeir M, Liberman AL, Moncrieffe K, Lu J, Sharma R, Cheng Y, Zubair AS, Simpkins AN, Li GT, Kung JC, Perez D, Heldner M, Scutelnic A, Seiffge D, Siepen B, Rothstein A, Khazaal O, Do D, Kasab SA, Rahman LA, Mistry EA, Kerrigan D, Lafever H, Nguyen TN, Klein P, Aparicio H, Frontera J, Kuohn L, Agarwal S, Stretz C, Kala N, El Jamal S, Chang A, Cutting S, Xiao H, de Havenon A, Muddasani V, Wu T, Wilson D, Nouh A, Asad SD, Qureshi A, Moore J, Khatri P, Aziz Y, Casteigne B, Khan M, Cheng Y, Mac Grory B, Weiss M, Ryan D, Vedovati MC, Paciaroni M, Siegler JE, Kamen S, Yu S, Leon Guerrero CR, Atallah E, De Marchis GM, Brehm A, Dittrich T, Psychogios M, Alvarado-Dyer R, Kass-Hout T, Prabhakaran S, Honda T, Liebeskind DS, Furie K. Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study. Stroke. 2022 03; 53(3):728-738.
PMID: 35143325

The minimal clinically important difference of the motricity index score.
Lin C, Arevalo YA, Harvey RL, Prabhakaran S, Martin KD. The minimal clinically important difference of the motricity index score. Top Stroke Rehabil. 2022 Jan 30; 1-6.
PMID: 35094664

Impact of mean blood pressure and blood pressure variability after diagnosis of mild cognitive impairment and risk of dementia.
de Havenon A, Muddasani V, Anadani M, Prabhakaran S. Impact of mean blood pressure and blood pressure variability after diagnosis of mild cognitive impairment and risk of dementia. J Clin Hypertens (Greenwich). 2021 12; 23(12):2124-2128.
PMID: 34862714

Self-Reported Race as a Social Determinant of Stroke Risk in Observational Versus Clinical Trial Datasets.
Herman AL, Sheth KN, Williams OA, Johnston KC, Prabhakaran S, de Havenon A. Self-Reported Race as a Social Determinant of Stroke Risk in Observational Versus Clinical Trial Datasets. J Stroke Cerebrovasc Dis. 2022 Feb; 31(2):106219.
PMID: 34826677

Lipid Levels and Short-Term Risk of Recurrent Brain Infarcts in Symptomatic Intracranial Stenosis.
Prabhakaran S, Liebeskind DS, Cotsonis G, Nizam A, Feldmann E, Sangha RS, Campo-Bustillo I, Romano JG. Lipid Levels and Short-Term Risk of Recurrent Brain Infarcts in Symptomatic Intracranial Stenosis. J Stroke Cerebrovasc Dis. 2022 Jan; 31(1):106141.
PMID: 34710776

Editorial: Intracranial Atherosclerotic Disease: Epidemiology, Imaging, Treatment and Prognosis.
Leng X, Prabhakaran S, Lee JS, Abou-Chebl A, Liebeskind DS. Editorial: Intracranial Atherosclerotic Disease: Epidemiology, Imaging, Treatment and Prognosis. Front Neurol. 2021; 12:729377.
PMID: 34744971

View All Publications